Enteric fever, primarily caused by Salmonella Typhi and Salmonella Paratyphi, is a systemic infection that continues to pose significant health challenges, particularly in endemic regions. Early diagnosis and effective treatment are crucial to control the spread and reduce morbidity and mortality associated with this disease.
The gold standard for diagnosing enteric fever is blood culture, which has a sensitivity of 40-60% in the first week of illness. However, it requires technical expertise and is time-consuming. Newer molecular techniques such as Polymerase Chain Reaction (PCR) and Nucleic Acid Amplification Tests (NAATs) offer higher sensitivity and specificity, and faster results. Serological tests like Widal Test are commonly used in resource-poor settings, but they have significant limitations in terms of sensitivity and specificity.
Antibiotic therapy is the mainstay of treatment for enteric fever. Choice of antibiotic should be guided by local susceptibility patterns as multi-drug resistant strains are increasingly common. Fluoroquinolones were once the drug of choice, but resistance has led to the use of third-generation cephalosporins like ceftriaxone and azithromycin. Vaccination is an effective preventive measure, especially for travelers to endemic areas and people living in high-risk regions.
Despite advances in diagnostic techniques and treatment options, challenges remain in controlling enteric fever. These include the emergence of antibiotic-resistant strains, limited access to diagnostic facilities in resource-poor settings, and lack of a highly effective vaccine. Continued research is needed to develop more effective vaccines and novel diagnostic tools. Public health measures such as improving sanitation and access to clean water are also crucial in controlling the spread of enteric fever.
Enteric fever remains a significant global health issue. While strides have been made in diagnosis and treatment, challenges persist. It is essential for healthcare professionals to stay abreast of current diagnostic methods and treatment strategies to effectively manage this disease and reduce its global impact.
1.
Extracellular matrix pathway emerges as treatment target for pediatric cancer
2.
Researchers explore e-bikes for cancer recovery
3.
According to new studies, some cancer patients can safely forego radiation therapy.
4.
In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.
5.
A single bout of exercise gives results that could help cancer patients
1.
Unlocking the Power of Hematocrit: Exploring the Benefits of Blood Cell Counts
2.
Undersanding Alemtuzumab: What You Need To Know About This Multiple Sclerosis Medication
3.
Clonal Hematopoiesis and Healthy Aging: Insights, Mechanisms, and Clinical Relevance
4.
Clinical Guidance for Survivorship-Focused Cancer Care
5.
Bone Marrow Regenerative Capacity and Hematologic Recovery
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
2.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
3.
Recognizing Symptoms of Vitamin B12 Deficiency
4.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
5.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation